Trials / Conditions / Non-segmental Vitiligo

Non-segmental Vitiligo

22 registered clinical trials studyying Non-segmental Vitiligo — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental NCT07431177	Novartis Pharmaceuticals	Phase 2
Recruiting	Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients NCT07223229	Elixiron Immunotherapeutics (Hong Kong) Ltd.	Phase 2
Recruiting	A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo NCT07251595	Jiangsu HengRui Medicine Co., Ltd.	Phase 2
Recruiting	Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo NCT07172347	Jiangsu vcare pharmaceutical technology co., LTD	Phase 2
Recruiting	An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediat NCT07105254	Derm Texas, PLLC	Phase 2
Completed	Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China NCT07058051	AbbVie	—
Recruiting	ICP-332 in Subjects With Non-segmental Vitiligo NCT07047612	Beijing InnoCare Pharma Tech Co., Ltd.	Phase 2 / Phase 3
Recruiting	Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients NCT06991972	Khyber Teaching Hospital	Phase 4
Active Not Recruiting	A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vi NCT06493578	Vyne Therapeutics Inc.	Phase 2
Recruiting	A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients NCT06511739	CSPC Ouyi Pharmaceutical Co., Ltd.	Phase 2
Terminated	A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007) NCT06113328	Merck Sharp & Dohme LLC	Phase 2
Unknown	ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO NCT05990309	Sohag University	N/A
Completed	Transplantation of Autologous Non-Cultured Extracted Hair Follicle Outer Root Sheath Cell Suspension and Mini NCT06619184	Universitas Padjadjaran	N/A
Completed	Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Par NCT04927975	AbbVie	Phase 2
Unknown	Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation NCT04811326	Shaimaa Fawzy Abdel-rady Abdel-latif	Phase 4
Completed	Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo NCT04487860	Ache Laboratorios Farmaceuticos S.A.	Phase 2
Completed	Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) NCT04057573	Incyte Corporation	Phase 3
Completed	The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients W NCT04942860	Nicolaus Copernicus University	Phase 3
Completed	Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) NCT04052425	Incyte Corporation	Phase 3
Terminated	ReNovaCell in Non-segmental Vitiligo NCT03022019	Netherlands Institute for Pigment Disorders	N/A
Completed	The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and NCT03247400	Nicolaus Copernicus University	Phase 1 / Phase 2
Unknown	Punchgrafting Techniques for Vitiligo NCT01377077	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 4